Below are the most recent publications written about "Streptococcus pneumoniae" by people in Profiles.
-
Walker EC, Javati S, Todd EM, Matlam JP, Lin X, Bryant M, Krone E, Ramani R, Chandra P, Green TP, Anaya EP, Zhou JY, Alexander KA, Tong RS, Yuasi L, Boluarte S, Yang F, Greenberg L, Nerbonne JM, Greenberg MJ, Clemens RA, Philips JA, Wilson LD, Halabi CM, DeBosch BJ, Blyth CC, Druley TE, Kazura JW, Pomat WS, Morley SC. Novel coenzyme Q6 genetic variant increases susceptibility to pneumococcal disease. Nat Immunol. 2024 Dec; 25(12):2247-2258.
-
Cravens MP, Alugupalli AS, Sandilya VK, McGeady SJ, Alugupalli KR. The Immunoglobulin M Response to Pneumococcal Polysaccharide Vaccine Is Sufficient for Conferring Immunity. J Infect Dis. 2022 11 11; 226(10):1852-1856.
-
Zafar A, Lalani FK, Longi AA, Jajja MR, Haider M, Hashmi S, Khan E, Irfan S, Hussain T, Hussain FR, Hasan R, Jabeen K. Increase in Penicillin and multidrug resistance in Streptococcus pneumoniae (1993-2016): Report from a tertiary care hospital laboratory, Pakistan. J Pak Med Assoc. 2021 Dec; 71(12):2726-2730.
-
Belde V, Cravens MP, Gulandijany D, Walker JA, Palomo-Caturla I, Alugupalli AS, Sandilya VK, Mahmoud T, B?umler AJ, Kearney JF, Alugupalli KR. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi. Infect Immun. 2018 09; 86(9).
-
Hajjar J, Al-Kaabi A, Kutac C, Dunn J, Shearer WT, Orange JS. Questioning the accuracy of currently available pneumococcal antibody testing. J Allergy Clin Immunol. 2018 10; 142(4):1358-1360.
-
Couch KA, Geide T. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance. Am J Health Syst Pharm. 2014 Mar 01; 71(5):417-24.
-
Snyder CM, Begor W, Berndt ER. Economic perspectives on the advance market commitment for pneumococcal vaccines. Health Aff (Millwood). 2011 Aug; 30(8):1508-17.
-
Patel SN, Pillai DR, Pong-Porter S, McGeer A, Green K, Low DE. In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008. J Antimicrob Chemother. 2009 Sep; 64(3):659-60.
-
Naidu BN, Sorenson ME, Matiskella JD, Li W, Sausker JB, Zhang Y, Connolly TP, Lam KS, Bronson JJ, Pucci MJ, Yang H, Ueda Y. Synthesis and antibacterial activity of nocathiacin I analogues. Bioorg Med Chem Lett. 2006 Jul 01; 16(13):3545-9.
-
Alugupalli KR, Gerstein RM. Divide and conquer: division of labor by B-1 B cells. Immunity. 2005 Jul; 23(1):1-2.